Recall
FDAHealthJanuary 17, 2025

McKesson — Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY

⚠️ cGMP Deviations: Product intended for quarantine was inadvertently distributed.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
January 17, 2025

Nationwide USA

What's affected?

Product
Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01
UPC
0300690809014
Lot code
04647349

Additional details

Lot# 04647349, Exp Date 5/31/2029

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 192 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.